ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 2.702
EU - Europa 1.173
AS - Asia 1.046
SA - Sud America 156
AF - Africa 16
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.098
Nazione #
US - Stati Uniti d'America 2.654
CN - Cina 385
PL - Polonia 366
SG - Singapore 323
UA - Ucraina 177
DE - Germania 172
BR - Brasile 142
HK - Hong Kong 135
IT - Italia 130
FI - Finlandia 90
GB - Regno Unito 68
VN - Vietnam 60
TR - Turchia 39
IE - Irlanda 34
RU - Federazione Russa 34
CA - Canada 30
FR - Francia 29
IN - India 22
SE - Svezia 17
BD - Bangladesh 16
ID - Indonesia 12
ES - Italia 11
MX - Messico 9
NL - Olanda 9
AR - Argentina 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
PK - Pakistan 7
BG - Bulgaria 6
KR - Corea 6
AT - Austria 5
BE - Belgio 5
JP - Giappone 5
LT - Lituania 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
KG - Kirghizistan 4
NI - Nicaragua 4
SA - Arabia Saudita 4
TW - Taiwan 4
UZ - Uzbekistan 4
CL - Cile 2
EC - Ecuador 2
EU - Europa 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
MA - Marocco 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 5.098
Città #
Warsaw 366
Fairfield 332
Ashburn 241
Woodbridge 234
Houston 174
Seattle 169
Singapore 168
Chandler 141
Jacksonville 132
Cambridge 117
Hong Kong 117
Wilmington 105
New York 101
Ann Arbor 93
Dearborn 92
Beijing 81
Los Angeles 64
Princeton 62
Helsinki 58
Nanjing 41
Brescia 37
Munich 36
Dublin 34
Istanbul 31
Shanghai 30
Des Moines 25
San Francisco 24
Dallas 21
Dong Ket 20
Jinan 20
Chicago 19
São Paulo 18
Buffalo 17
Shenyang 16
The Dalles 16
Toronto 16
London 14
Milan 14
Turku 14
Central 13
Changsha 13
Moscow 12
Nanchang 12
Hangzhou 11
Hebei 11
Santa Clara 11
Kunming 10
Belo Horizonte 9
Ho Chi Minh City 9
Jiaxing 9
Rome 9
Stockholm 9
Tianjin 9
Denver 8
Hanoi 8
Jakarta 8
Poplar 8
Redondo Beach 8
San Diego 8
Ankara 7
Guangzhou 7
Brooklyn 6
Chennai 6
Falkenstein 6
Lanzhou 6
Monmouth Junction 6
Boston 5
Brno 5
Brussels 5
Hefei 5
Mexico City 5
Norwalk 5
Phoenix 5
Sofia 5
Zhengzhou 5
Bishkek 4
Cazzago San Martino 4
Lahore 4
Leawood 4
Managua 4
Manchester 4
Milton Keynes 4
Montreal 4
Mumbai 4
Nardò 4
Ningbo 4
Orem 4
Paris 4
Tashkent 4
Tokyo 4
Vienna 4
Atlanta 3
Biên Hòa 3
Campinas 3
Charlotte 3
Curitiba 3
Desio 3
Fuzhou 3
Gunzenhausen 3
Haikou 3
Totale 3.685
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 326
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 311
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 196
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 185
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 180
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 174
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 172
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 172
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 170
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 166
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 165
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 162
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 161
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 160
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 157
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 154
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 146
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 143
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 140
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 134
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 131
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 123
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 120
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 116
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 109
Oxide nanobelts as conductometric gas sensors 106
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 99
Gas sensitive light emission properties of tin oxide nanobelts 95
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 90
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 88
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 83
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 75
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 56
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 40
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 17
Totale 5.186
Categoria #
all - tutte 22.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021457 0 0 0 0 0 55 35 80 62 121 64 40
2021/2022337 43 59 5 4 1 15 24 16 11 46 43 70
2022/2023361 57 24 19 25 28 67 3 37 63 4 16 18
2023/2024457 26 11 46 33 23 111 23 36 75 26 8 39
2024/2025705 6 15 7 103 45 85 54 35 72 42 150 91
2025/2026889 165 166 110 231 209 8 0 0 0 0 0 0
Totale 5.186